Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release Guanfacine HCl maintenance in pediatric ADHD
NCT01081145Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started May 2010; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01081145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081145.